Clinical Trials
🇺🇸 FDA Page 19FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Access global clinical trial data, regulatory updates, and competitive intelligence for strategic pharma R&D and investment decisions.
Showing 217–228 of 380 articles
AC Immune Advances ACI-24 Alzheimer's Trial to Final Cohort, Initiates ACI-19764 Phase 1 Study
Addex Advances Dipraglurant for Brain Injury Recovery, Reports 2025 Financial Results
AC Immune Initiates Final Cohort in Phase 1b/2 ABATE Trial for Anti-Abeta Alzheimer's Treatment
Mabwell 9MW2821 Cervical Cancer Data to Be Presented at ESMO GC 2026 Conference
FDA Advisory Committee Recommends AstraZeneca's TRUQAP for PTEN-Deficient Prostate Cancer
Eli Lilly's Foundayo (Orforglipron) Receives FDA Approval for Obesity Treatment as Company Reports Strong Q1 2026 Results
Theradaptive Receives FDA Approval for Pivotal Phase 3 Trial of OsteoAdapt SP in Spinal Fusion
Alzheimer's Clinical Trial Failures: Insights from Semaglutide & Posdinemab FDA Trials
Viking Therapeutics VK2735 Phase 3 Obesity Trials Fully Enrolled as Company Reports Q1 2026 Results
Relay Therapeutics Q1 2026 Earnings: Zovegalisib PI3Kα Inhibitor Updates Expected May 5
Neurocrine Biosciences INGREZZA Shows Clinically Meaningful Improvement in Tardive Dyskinesia Study
Novo Nordisk's Denecimig Shows Significant Bleeding Reduction in Hemophilia A Phase 3 Trial Published in NEJM